2012
DOI: 10.1016/j.jviromet.2011.10.007
|View full text |Cite
|
Sign up to set email alerts
|

Detection of enterovirus RNA in cerebrospinal fluid: Comparison of two molecular assays

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

2
10
1

Year Published

2013
2013
2024
2024

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 23 publications
(13 citation statements)
references
References 31 publications
2
10
1
Order By: Relevance
“…The purpose of performing our assay in separate reactions is to achieve specific and simultaneous detection, without the risk of cross-contamination. Using this method, 100% sensitivity was obtained for the 3 viruses, and we observed no cross-reactions with any of the viruses analyzed; additionally, specificities with high values were achieved (EV: 96%, HSV1: 100%, and HSV2: 94%), similar to those reported with the end-point and other real-time techniques, and even higher than the specificity achieved with other commercial kits [7,11,[16][17][18][19][20][21] . These results indicate that the sequences used for the primers and probes are specific; in the case of EV, the primers allow the identification of all viruses grouped in the genus, as the target sequence is highly conserved among its members; in the case of HSV1 and HSV2, as the primers are aimed at 2 different targets, this protocol can achieve differential diagnosis between these 2 viruses, without observing the cross-reactions that have been reported in other studies that use different areas of the same target [22][23][24] .…”
supporting
confidence: 83%
“…The purpose of performing our assay in separate reactions is to achieve specific and simultaneous detection, without the risk of cross-contamination. Using this method, 100% sensitivity was obtained for the 3 viruses, and we observed no cross-reactions with any of the viruses analyzed; additionally, specificities with high values were achieved (EV: 96%, HSV1: 100%, and HSV2: 94%), similar to those reported with the end-point and other real-time techniques, and even higher than the specificity achieved with other commercial kits [7,11,[16][17][18][19][20][21] . These results indicate that the sequences used for the primers and probes are specific; in the case of EV, the primers allow the identification of all viruses grouped in the genus, as the target sequence is highly conserved among its members; in the case of HSV1 and HSV2, as the primers are aimed at 2 different targets, this protocol can achieve differential diagnosis between these 2 viruses, without observing the cross-reactions that have been reported in other studies that use different areas of the same target [22][23][24] .…”
supporting
confidence: 83%
“…The increase in EV reporting in recent years closely reflects the increase in PCR testing, which was also associated with a lower proportion of samples being submitted to the national reference department for confirmation and typing. The high sensitivity of PCR as compared with cell culture will also have contributed to the number of laboratory-confirmed cases [12][13][14][15], and this trend is likely to continue as more sensitive multiplex assays for simultaneous detection of multiple pathogens in biological samples are adopted by local hospitals. In addition to being cheap, rapid, and sensitive, PCR testing for EV can directly impact on individual patient care by reducing unnecessary antibiotic usage and shortening hospital stays.…”
Section: Discussionmentioning
confidence: 99%
“…PCR testing is cheaper, rapid, requires small amounts of biological material, can be used for multiple pathogens, and can detect almost all EV types, because the viruses share common genetic sequences. For EVs, PCR has greater sensitivity and specificity than viral cultures [12][13][14][15]. Data from these studies show that it is possible to deliver a result within 5-6 h of sample testing, which could, in turn, deliver significant cost savings by reducing unnecessary antimicrobial use and shortening hospital stays.…”
Section: Introductionmentioning
confidence: 99%
“…25 Detection frequencies for hPeV in diverse cohorts range from 2.3% to 4.6% in cerebrospinal fluid (CSF). [29][30][31] Our aim was to assess prevalence, epidemiology and clinical presentation of CNS infections with hPeV and compare it to that of EV in our patient population. 27,28 Polymerase chain reaction (PCR) has repeatedly been demonstrated to be superior to viral culture in detecting hPeV in clinical specimens.…”
mentioning
confidence: 99%